Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload

Mark J. Ranek, Hanqiao Zheng, Wei Huang, Asangi R. Kumarapeli, Jie Li, Jinbao Liu, Xuejun Wang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The in vivo function status of the ubiquitin-proteasome system (UPS) in pressure overloaded hearts remains undefined. Cardiotoxicity was observed during proteasome inhibitor chemotherapy, especially in those with preexisting cardiovascular conditions; however, proteasome inhibition (PsmI) was also suggested by some experimental studies as a potential therapeutic strategy to curtail cardiac hypertrophy. Here we used genetic approaches to probe cardiac UPS performance and determine the impact of cardiomyocyte-restricted PsmI (CR-PsmI) on cardiac responses to systolic overload. Transgenic mice expressing an inverse reporter of the UPS (GFPdgn) were subject to transverse aortic constriction (TAC) to probe myocardial UPS performance during systolic overload. Mice with or without moderate CR-PsmI were subject to TAC and temporally characterized for cardiac responses to moderate and severe systolic overload. After moderate TAC (pressure gradient: ~. 40. mm. Hg), cardiac UPS function was upregulated during the first two weeks but turned to functional insufficiency between 6 and 12. weeks as evidenced by the dynamic changes in GFPdgn protein levels, proteasome peptidase activities, and total ubiquitin conjugates. Severe TAC (pressure gradients >. 60. mm. Hg) led to UPS functional insufficiency within a week. Moderate TAC elicited comparable hypertrophic responses between mice with and without genetic CR-PsmI but caused cardiac malfunction in CR-PsmI mice significantly earlier than those without CR-PsmI. In mice subject to severe TAC, CR-PsmI inhibited cardiac hypertrophy but led to rapidly progressed heart failure and premature death, associated with a pronounced increase in cardiomyocyte death. It is concluded that cardiac UPS function is dynamically altered, with the initial brief upregulation of proteasome function being adaptive; and CR-PsmI facilitates cardiac malfunction during systolic overload.

Original languageEnglish (US)
Pages (from-to)273-281
Number of pages9
JournalJournal of Molecular and Cellular Cardiology
Volume85
DOIs
StatePublished - Aug 1 2015
Externally publishedYes

Fingerprint

Proteasome Endopeptidase Complex
Cardiac Myocytes
Heart Failure
Ubiquitin
Constriction
Cardiomegaly
Arterial Pressure
Preexisting Condition Coverage
Proteasome Inhibitors
Premature Mortality
Transgenic Mice
Peptide Hydrolases
Up-Regulation
Pressure
Drug Therapy

Keywords

  • Cardiac hypertrophy
  • Heart failure
  • Pressure overload
  • Proteasome inhibition
  • Transgenic mice
  • Ubiquitin-proteasome system

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload. / Ranek, Mark J.; Zheng, Hanqiao; Huang, Wei; Kumarapeli, Asangi R.; Li, Jie; Liu, Jinbao; Wang, Xuejun.

In: Journal of Molecular and Cellular Cardiology, Vol. 85, 01.08.2015, p. 273-281.

Research output: Contribution to journalArticle

Ranek, Mark J. ; Zheng, Hanqiao ; Huang, Wei ; Kumarapeli, Asangi R. ; Li, Jie ; Liu, Jinbao ; Wang, Xuejun. / Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload. In: Journal of Molecular and Cellular Cardiology. 2015 ; Vol. 85. pp. 273-281.
@article{89947f55702e4aa29e01f7b5206366f4,
title = "Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload",
abstract = "The in vivo function status of the ubiquitin-proteasome system (UPS) in pressure overloaded hearts remains undefined. Cardiotoxicity was observed during proteasome inhibitor chemotherapy, especially in those with preexisting cardiovascular conditions; however, proteasome inhibition (PsmI) was also suggested by some experimental studies as a potential therapeutic strategy to curtail cardiac hypertrophy. Here we used genetic approaches to probe cardiac UPS performance and determine the impact of cardiomyocyte-restricted PsmI (CR-PsmI) on cardiac responses to systolic overload. Transgenic mice expressing an inverse reporter of the UPS (GFPdgn) were subject to transverse aortic constriction (TAC) to probe myocardial UPS performance during systolic overload. Mice with or without moderate CR-PsmI were subject to TAC and temporally characterized for cardiac responses to moderate and severe systolic overload. After moderate TAC (pressure gradient: ~. 40. mm. Hg), cardiac UPS function was upregulated during the first two weeks but turned to functional insufficiency between 6 and 12. weeks as evidenced by the dynamic changes in GFPdgn protein levels, proteasome peptidase activities, and total ubiquitin conjugates. Severe TAC (pressure gradients >. 60. mm. Hg) led to UPS functional insufficiency within a week. Moderate TAC elicited comparable hypertrophic responses between mice with and without genetic CR-PsmI but caused cardiac malfunction in CR-PsmI mice significantly earlier than those without CR-PsmI. In mice subject to severe TAC, CR-PsmI inhibited cardiac hypertrophy but led to rapidly progressed heart failure and premature death, associated with a pronounced increase in cardiomyocyte death. It is concluded that cardiac UPS function is dynamically altered, with the initial brief upregulation of proteasome function being adaptive; and CR-PsmI facilitates cardiac malfunction during systolic overload.",
keywords = "Cardiac hypertrophy, Heart failure, Pressure overload, Proteasome inhibition, Transgenic mice, Ubiquitin-proteasome system",
author = "Ranek, {Mark J.} and Hanqiao Zheng and Wei Huang and Kumarapeli, {Asangi R.} and Jie Li and Jinbao Liu and Xuejun Wang",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.yjmcc.2015.06.014",
language = "English (US)",
volume = "85",
pages = "273--281",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload

AU - Ranek, Mark J.

AU - Zheng, Hanqiao

AU - Huang, Wei

AU - Kumarapeli, Asangi R.

AU - Li, Jie

AU - Liu, Jinbao

AU - Wang, Xuejun

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The in vivo function status of the ubiquitin-proteasome system (UPS) in pressure overloaded hearts remains undefined. Cardiotoxicity was observed during proteasome inhibitor chemotherapy, especially in those with preexisting cardiovascular conditions; however, proteasome inhibition (PsmI) was also suggested by some experimental studies as a potential therapeutic strategy to curtail cardiac hypertrophy. Here we used genetic approaches to probe cardiac UPS performance and determine the impact of cardiomyocyte-restricted PsmI (CR-PsmI) on cardiac responses to systolic overload. Transgenic mice expressing an inverse reporter of the UPS (GFPdgn) were subject to transverse aortic constriction (TAC) to probe myocardial UPS performance during systolic overload. Mice with or without moderate CR-PsmI were subject to TAC and temporally characterized for cardiac responses to moderate and severe systolic overload. After moderate TAC (pressure gradient: ~. 40. mm. Hg), cardiac UPS function was upregulated during the first two weeks but turned to functional insufficiency between 6 and 12. weeks as evidenced by the dynamic changes in GFPdgn protein levels, proteasome peptidase activities, and total ubiquitin conjugates. Severe TAC (pressure gradients >. 60. mm. Hg) led to UPS functional insufficiency within a week. Moderate TAC elicited comparable hypertrophic responses between mice with and without genetic CR-PsmI but caused cardiac malfunction in CR-PsmI mice significantly earlier than those without CR-PsmI. In mice subject to severe TAC, CR-PsmI inhibited cardiac hypertrophy but led to rapidly progressed heart failure and premature death, associated with a pronounced increase in cardiomyocyte death. It is concluded that cardiac UPS function is dynamically altered, with the initial brief upregulation of proteasome function being adaptive; and CR-PsmI facilitates cardiac malfunction during systolic overload.

AB - The in vivo function status of the ubiquitin-proteasome system (UPS) in pressure overloaded hearts remains undefined. Cardiotoxicity was observed during proteasome inhibitor chemotherapy, especially in those with preexisting cardiovascular conditions; however, proteasome inhibition (PsmI) was also suggested by some experimental studies as a potential therapeutic strategy to curtail cardiac hypertrophy. Here we used genetic approaches to probe cardiac UPS performance and determine the impact of cardiomyocyte-restricted PsmI (CR-PsmI) on cardiac responses to systolic overload. Transgenic mice expressing an inverse reporter of the UPS (GFPdgn) were subject to transverse aortic constriction (TAC) to probe myocardial UPS performance during systolic overload. Mice with or without moderate CR-PsmI were subject to TAC and temporally characterized for cardiac responses to moderate and severe systolic overload. After moderate TAC (pressure gradient: ~. 40. mm. Hg), cardiac UPS function was upregulated during the first two weeks but turned to functional insufficiency between 6 and 12. weeks as evidenced by the dynamic changes in GFPdgn protein levels, proteasome peptidase activities, and total ubiquitin conjugates. Severe TAC (pressure gradients >. 60. mm. Hg) led to UPS functional insufficiency within a week. Moderate TAC elicited comparable hypertrophic responses between mice with and without genetic CR-PsmI but caused cardiac malfunction in CR-PsmI mice significantly earlier than those without CR-PsmI. In mice subject to severe TAC, CR-PsmI inhibited cardiac hypertrophy but led to rapidly progressed heart failure and premature death, associated with a pronounced increase in cardiomyocyte death. It is concluded that cardiac UPS function is dynamically altered, with the initial brief upregulation of proteasome function being adaptive; and CR-PsmI facilitates cardiac malfunction during systolic overload.

KW - Cardiac hypertrophy

KW - Heart failure

KW - Pressure overload

KW - Proteasome inhibition

KW - Transgenic mice

KW - Ubiquitin-proteasome system

UR - http://www.scopus.com/inward/record.url?scp=84934280934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934280934&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2015.06.014

DO - 10.1016/j.yjmcc.2015.06.014

M3 - Article

VL - 85

SP - 273

EP - 281

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -